AETHLON MEDICAL INC (AEMD)
US00808Y4061 - Common Stock
AETHLON MEDICAL INC
NASDAQ:AEMD (4/24/2024, 7:00:00 PM)
1.53
+0.02 (+1.2%)
Company Profile
Aethlon Medical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in San Diego, California and currently employs 15 full-time employees. Aethlon Medical, Inc. (Aethlon) is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections suppression, seed the spread of metastasis and inhibit the benefit of cancer therapies. The Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression. Hemopurifier helps to bind and clear multiple different glycosylated viruses, such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), Dengue, West Nile, multiple strains of influenza, Ebola, Chikungunya, smallpox, monkeypox, multiple herpes viruses, a MERS-CoV related pseudovirus, and others. Hemopurifier is used as a device for two independent indications: the treatment of individuals with advanced or metastatic cancer and the treatment of life threating viruses that are not approved therapies.
Company Info
AETHLON MEDICAL INC
11555 Sorrento Valley Road, Suite 203
San Diego CALIFORNIA 92123
P: 18584597800
CEO: Charles J. Fisher Jr
Employees: 15
Website: https://www.aethlonmedical.com/
AEMD News
2 months ago - Aethlon Medical, Inc.Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
2 months ago - Aethlon Medical, Inc.Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
5 months ago - Aethlon Medical, Inc.Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
5 months ago - Seeking AlphaAethlon Medical gets new chief head (NASDAQ:AEMD)Aethlon Medical announced the appointment of James B. Frakes as interim CEO and CFO, replacing Charles J. Fisher, Jr., M.D.
5 months ago - Aethlon Medical, Inc.Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
7 months ago - Aethlon Medical, Inc.Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening viral...
AEMD Twits
Here you can normally see the latest stock twits on AEMD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
